BackPoniard Pharmaceuticals Overview

Poniard Pharmaceuticals Current Assets

Latest current assets for PARD: $2.3M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$2.25M
↓ 90.75% YoYΔ $-22.11M vs prior year quarter

Peer trimmed avg / median

Loading

Poniard Pharmaceuticals Current Assets History

Loading

Poniard Pharmaceuticals vs. peers: Current Assets Comparison

Loading

Poniard Pharmaceuticals Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Poniard Pharmaceuticals (PARD) FAQ

Poniard Pharmaceuticals's current assets stands at $2.3M as of September 2011. That compares with $24M in the prior-year period — down 90.8% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Poniard Pharmaceuticals reported $2.3M in current assets versus $24M a year earlier — a 90.8% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $24M in the prior-year period — down 90.8% year over year. Sustained growth in current assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Poniard Pharmaceuticals's current assets evolved across reporting periods, while the comparison chart places PARD next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, current assets is commonly used to spot outliers. Poniard Pharmaceuticals's reading of $2.3M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.